The development of sympathetic overactivity and hypertension in rats submitted to chronic intermittent hypoxia (CIH) involve alterations in the central mechanisms controlling respiratory and autonomic functions. Herein, we assessed whether CIH alters glutamatergic and/or purinergic signaling in the ventrolateral medulla (VLM), a region that encompasses the pre-sympathetic neurons and respiratory neurons of the ventral respiratory column. Groups of juvenile rats were exposed for 10 days to CIH (6% O 2 for 40 s, every 9 min, 8 h/day) or normoxia (controls). Following treatment, in situ working heart-brainstem preparations were performed to record simultaneously respiratory and sympathetic motor outputs. In separate CIH and control groups, the VLM was dissected for western-blot analyses of ionotropic glutamatergic and P2 receptors. L-glutamate microinjections (1, 3 or 10 mM) into VLM of control (n= 6) and CIH groups (n= 10) produced similar increases of sympathetic and abdominal activities associated with phrenic nerve inhibition; immunoreactive NMDAR1 and GluR2/3 densities at the VLM were also alike between groups (n= 4). In contrast, VLM microinjections of ATP (1, 10 or 50 mM) evoked larger sympatho-excitatory responses in CIH (n= 8) than in control rats (n= 7, P b 0.05) whilst the abdominal increase and phrenic nerve inhibition were of comparable magnitudes. The immunoreactive densities of P2X3 and P2X4 receptors, but not P2X1 and P2Y2, were 20% higher in VLM of CIH (n= 8; P b 0.05) than controls (n = 8). Altogether, our findings suggest that CIH augments purinergic signaling in the VLM, supporting the concept that nucleotides play a role in the dynamic central control of the sympathetic autonomic function.
Introduction
Peripheral chemoreceptors, mainly located in the carotid bodies, play a key role in monitoring oxygen in the arterial blood and activating neural mechanisms that evoke respiratory and cardiovascular adjustments in response to acute hypoxia (Machado, 2001 (Machado, , 2004 Lahiri et al., 2006) . Chronically, the overactivation of peripheral chemoreceptors has been associated with the development of cardiovascular and respiratory dysfunctions (Caples et al., 2005; Durán-Cantolla et al., 2009) . Such condition can be observed in patients suffering of obstructive sleep apnea (OSA), which experience chronic intermittent hypoxia (CIH) due to the repetitive obstructions of the upper airways during sleep (Dempsey et al., 2010) . Clinical studies show that long-term exposure to episodic hypoxia is an important risk factor contributing to cardiovascular dysfunctions in OSA patients, mainly arterial hypertension (Somers, 1995; Leuenberger et al., 2005) . In rats, we demonstrated that the exposure to CIH elicited an increased basal sympathetic activity, which was determinant to elevate arterial pressure in these animals (Fletcher, 2001; Zoccal et al., 2007 Zoccal et al., , 2008 Zoccal et al., , 2009 . These data indicate that alterations in the sympathetic nervous system contribute to the development of arterial hypertension in CIH rats. However, the neurochemical mechanisms involved remain to be established.
A cluster of neurons located in the rostral aspect of ventrolateral medulla (VLM) that provide excitatory drive to pre-ganglionic neurons in the spinal cord has been considered pivotal for the generation of sympathetic activity (Guyenet, 2006) . At the same level, and along with the pre-sympathetic VLM neurons, it is also found part of the inspiratory and expiratory neurons of ventral respiratory column (VRC) that play a dominant role in the generation of respiratory rhythm (Bianchi et al., 1995; Feldman and Del Negro, 2006; Abdala et al., 2009) . It has been suggested that VRC neurons modulate the pre-sympathetic neuronal activity and contribute for the generation of the respiratory modulation of sympathetic activity in normoxic (Haselton and Guyenet, 1989) as well as in hypoxic conditions (Mandel and Schreihofer, 2009 ). This central entrainment between respiratory and sympathetic neurons appears to be altered in CIH rats. We previously reported that rats submitted to CIH exhibit an additional burst of activity in sympathetic nerves phase-locked with the emergence of a novel burst of activity in abdominal expiratory motor nerves during the late part of expiration (Zoccal et al., 2008) . These data pointed out a strengthened interaction between sympathetic and expiratory neurons in CIH rats, not seen in controls, suggesting that alterations in the neurochemical mechanisms underlying central respiratory-sympathetic coupling at the VLM contributes to the increased sympathetic activity observed after CIH .
L-glutamate is a major excitatory transmitter released in the VLM after the activation of peripheral chemoreceptors, leading to the excitation of pre-sympathetic (Sun and Reis, 1995) and respiratory neurons (Richter et al., 1999) . However, within the past few years, the role of adenosine-5′-triphosphate (ATP) in the VLM has been recognized and thought to play an increasingly interesting function (Rong et al., 2003; Gourine et al., 2005 Gourine et al., , 2010 Huxtable et al., 2010) . In hypoxia, the processing of tachypneic reflex response involves the release of ATP at the VLM level, specifically in an area encompassing the respiratory neurons of the Bötzinger and pre-Bötzinger complexes as well the neurons of the retrotrapezoid nucleus (Gourine et al., 2005) . Moreover, ATP microinjections in the VLM produced an increase of arterial pressure mediated by P2X receptor activation, suggesting an excitatory effect of ATP on pre-sympathetic neurons of VLM (Thomas et al., 2001) . Thereby, as far as both glutamatergic and purinergic systems are relevant for chemoreflex responses processing, we explored possible changes in glutamatergic or purinergic signaling in the VLM of rats submitted to CIH. We evaluated the sympathetic and respiratory responses to exogenous L-glutamate or ATP applications and assessed by western blot analysis the immunoreactivity of ionotropic glutamatergic and some P2X and P2Y receptors in the VLM of rats exposed to CIH and their matched paired controls. The present results indicate that the sympatho-excitatory responses to ATP, but not L-glutamate, is increased in CIH rats, a finding paralleled by a 20% increase in P2X3 and P2X4, but not P2X1 or P2Y2 receptor immunoreactivity in the VLM.
Methods

Animals and ethical committee approval
Juvenile male Wistar rats (19-21 days) obtained from the Animal Care Facility of the University of São Paulo at Ribeirão Preto, Brazil, were divided in two experimental groups: those exposed to chronic intermittent hypoxia (CIH group, n =39) and the matched normoxia controls (control group, n=35). All experimental protocols were approved by local Ribeirão Preto Ethical Committee on Animal Experimentation of the School of Medicine of Ribeirão Preto (protocol 019/2006).
Procedure for the chronic intermittent hypoxia
The CIH and control groups of rats were housed in collective cages and maintained in Plexiglas chambers (volume, 210 L) equipped with gas injectors and O 2 , CO 2 , humidity and temperature sensors. The CIH group was exposed to 5 min of normoxia (fraction of inspired O 2 , FiO 2 , of 20.8%) followed by 4 min of N 2 injection to reduce FiO 2 to 6%. After 30-40 s of hypoxia, O 2 was injected to return FiO 2 back to 20.8%. This 9-min cycle was repeated 8 h a day (from 9.30 am to 5.30 pm) for 10 days. During the remaining 16 h, the animals were exposed to 20.8% FiO 2 . The injections of N 2 and O 2 (White Martins, Sertãozinho, Brazil) were regulated by a solenoid valve system whose openingclosing control was operated by a computerized system (Oxycycler, Biospherix, New York, USA). In the same room, in a side-by-side identical chamber, the control rats were exposed to 20.8% FiO 2 24 h a day for 10 days. The control rats were also exposed to a similar valve noise as that experienced by the CIH group, except that FiO 2 was maintained at 20.8%. Gas injections were delivered through the upper part of the chambers, to avoid stress due to direct jets of gas that could impact on the animals.
In situ arterially-perfused preparation
Working heart-brainstem preparations from control (n = 11) and CIH rats (n = 15) were surgically prepared on the 11th day of the experimental protocol, as previously described (Paton, 1996; Zoccal et al., 2008) . Briefly, rats were deeply anesthetized with halothane (AstraZeneca do Brazil Ltda., Cotia, SP, Brazil) until loss of the paw withdrawal reflex, transected caudal to the diaphragm, submerged in a cooled Ringer solution (in mM: NaCl, 125; NaHCO 3 , 24; KCl, 5; CaCl 2 , 2.5; MgSO 4 , 1.25; KH 2 PO 4 , 1.25; dextrose, 10) and decerebrated at the precollicular level. This procedure rendered the rats pain insensible. Preparations were then transferred to a recording chamber, the descending aorta was cannulated and perfused retrogradely with Ringer solution containing 1.25% Ficoll (an oncotic agent) and a neuromuscular blocker (vecuronium bromide, 3-4 μg/ml, Cristália Produtos Químicos Farmacêuticos Ltda, São Paulo, Brazil), using a roller pump (Watson-Marlow 502 s, Falmouth, Cornwall, UK) via a double-lumen cannula. The perfusion pressure was maintained in the range of 50-70 mm Hg by adjusting the flow between 21 and 25 ml/ min and by adding 600-1200 pM of vasopressin to the perfusate. The perfusate was continuously gassed with 5% CO 2 and 95% O 2 (White Martins, Sertãozinho, Brazil), warmed to 31-32°C (temperature measured at the point of entry into the aorta) and filtered using a nylon mesh (pore size: 25 μm, Millipore, Billirica, MA, USA).
Nerve recordings and data analyses
Cardiorespiratory motor nerves were isolated and recorded simultaneously using bipolar glass suction electrodes held in micromanipulators (Narishige, Tokyo, Japan). Left phrenic nerve (PN) discharges were recorded from its central end and its rhythmic ramping activity was used as a continuous physiological index of preparation viability. The efferent activity of the left thoracic sympathetic nerve (tSN) was recorded from the sympathetic chain at T8-T12 level. An abdominal nerve (Abd) was isolated from the abdominal muscles on the right at lumbar level, cut distally and its efferent activity recorded. All the signals were amplified, band-pass filtered (0.5-5 kHz) and acquired in an A/D converter (CED micro 1401, Cambridge Electronic Design, CED, Cambridge, UK) to a computer using Spike 2 software (5 kHz, CED). The frequency of phrenic discharges was determined by the time interval between consecutive integrated phrenic peak bursts. Thoracic sympathetic and abdominal nerve activities were assessed as the area under the curve. The evoked alterations in all nerve activities were determined as the percentage of change in relation to the respective baseline activity prior to the stimulus. All the analyses were carried out on rectified and integrated signals (time constant of 50 ms) and performed off-line using Spike 2 software with custom-written scripts.
Microinjections into the VLM region
Different concentrations of L-glutamate or ATP were microinjected into the rostral aspect of VLM of control and CIH in situ preparations, where the pre-sympathetic VLM neurons are found and the rostral portion of the ventral respiratory column, mostly expiratory neurons of Bötzinger complex (BötC) (Sun et al., 1988; Smith et al., 1991; Sun et al., 1994; Smith et al., 2007) . The rostral VLM was approached dorsally using the following coordinates: 1.2-1.3 mm rostral to calamus scriptorius, 1.6 lateral to midline and 2.7-2.9 ventral to dorsal surface of medulla. Microinjections of 1, 3 or 10 mM of L-glutamate (Ito et al., 2001; Mueller et al., 2011; Moraes et al., in press) , and 1, 10 or 50 mM of ATP (Thomas et al., 2001; Moraes et al., in press ), were performed in separate groups of animals using three-barrel glass pipettes connected to pico-pump system (Picospritzer II, Parker Instruments, OH, USA). A time interval of 10-15 min was allowed between consecutive microinjections and at each time the volume injected was 20-30 nL.
Histology
At the end of each experiment, 1% Evans Blue was microinjected into the rostral VLM. The brainstem was then rapidly removed and fixed by immersion for 5 days in 10% buffered formalin. Serial transverse sections of 18 μm were cut using a cryostat and stained with cresyl violet using the Nissl method. To confirm that the microinjections were delivered to the rostral VLM, the coronal brainstem sections of each rat were analyzed by optical microscopy.
Western blot
Separate groups of CIH (n =24) and control animals (n=24) were deeply anesthetized with halothane; animals were decapitated to rapidly remove the brain. The brainstem was frozen in dry ice; using a cryostat, slices of 900-μm thickness were performed 1.2 mm rostral to the calamus scriptorius and prepared to obtain 1 mm diameter bilateral punches of the VLM which contains pre-sympathetic neurons and respiratory neurons of BötC/pre-BötC (Paxinos and Watson, 1998) . Punches from 3 animals were pooled; chopped on ice using a pestle with 1 mL of lysis buffer (Hepes 50 mM; NaCl 150 mM; MgCl2 2 mM; EGTA 1 mM; Triton 1%; Glycerol 10%, pH 7.4) plus 52 mg/mL phenylmethanesulfonyl fluoride. The homogenate was incubated for 30 min at 4°C, followed by a 15 min centrifugation at 15,000 g at 4°C. Supernatants were separated and stored at −20°C. The total protein for each sample was determined using the BCA protein assay kit (Amersham Biosciences, Piscataway, NJ). Ten micrograms of protein from each sample (pool of 3 animal samples) were denatured and separated by SDS-PAGE 10% in Tris-glycine buffer. The electrophoresed proteins were blotted onto PVDF membranes (Thermo Scientific, Rockford, USA) and incubated with rabbit anti-NMDAR1 (1:2000), rabbit anti-GluR2/3 (1:1000), rabbit anti-P2X1 (1:1000), goat anti-P2X3 (1:500), goat anti-P2X4 (1:500), goat-P2Y2 (1:1000) or mouse anti-α-tubulin (1:15,000) antibodies. The immunoreacive bands were visualized by incubation with the horseradish peroxidase-conjugated with anti-rabbit (1:5000), anti-goat (1:5000), or anti-mouse IgG (1:5000), which were detected using a enhanced chemiluminescence (Super Signal, Thermo Scientific) and a radiographic film (Hyperfilm ECL, Amersham). Immunoreactive bands were quantified by densitometry using the NIH Image J 1.40 software (National Institute of Health, USA; http://rsbweb.nih.gov/ij/). Relative amounts of P2X1, P2X3, P2X4, P2Y2, NMDAR1 and GluR2/3 detected were normalized with respect to α-tubulin and expressed in arbitrary units (au).
Statistical analyses
The results were expressed as mean± standard error and compared using two-way ANOVA followed by Bonferroni post-hoc or Student's unpaired t test. The comparisons were carried out on GraphPad Prism software (GraphPad Software, version 4) and differences were considered significant at P b 0.05.
Drugs and providers
All the drugs and salts for buffers were purchased from Sigma (St Louis, MO, USA). Antibodies were obtained from Calbiochem (La Jolla, USA; anti-NMDAR1), Chemicon International (Temecula, USA; anti-GluR2/3), Santa Cruz Biotechnologies (Santa Cruz, USA; anti-P2X1, anti-P2X3, anti-P2X4, anti-P2Y2, anti-rabbit, anti-goat and anti-mouse IgG) and Sigma (anti-α-tubulin).
Results
Microinjections of L-glutamate into the VLM
L-glutamate microinjections into the rostral VLM increased tSN and Abd activities and evoked a small reduction in phrenic burst frequency in CIH and control groups (Fig. 1A) . The magnitude of the 3 mM glutamate-evoked abdominal (109 ± 23 vs 93± 16%, Fig. 2A 1 ) and sympathetic excitatory responses (76 ± 7 vs 77± 12%, Fig. 3A) as well as the phrenic inhibitory responses (− 24.6 ± 4.4 vs − 30.0 ± 5.3%, Fig. 2A 2 ) were similar between CIH (n = 10) and the controls (n= 6). Likewise, the magnitude of phrenic inhibitory responses elicited by 1 (−33.2 ± 2.1 vs −32.5 ± 2.9%) or 10 mM (−21.2 ± 9.1 vs −34.4 ± 5.9%) L-glutamate, as well as the associated sympatho-excitatory responses elicited by 1 mM (71 ± 12 vs 47± 9%) or 10 mM (98 ± 12 vs 74 ± 10%, Fig. 3A) , were not different between CIH (n= 4) and control rats (n = 5). Microinjection sites were histologically confirmed (Fig. 4) . 
Microinjections of ATP into the VLM
ATP produced excitation of tSN and Abd activities associated with an inhibition of phrenic burst discharges in both CIH (n =8) and control rats (n=7) (Fig. 1B) when injected into the rostral VLM. The magnitude of the Abd response induced by 1 (219± 72 vs 131± 33%), 10 (223±45 vs 226± 52%; Fig. 2B 1 ) or 50 mM ATP (455±86 vs 325± 95%) was similar within groups. Likewise, the magnitude of phrenic frequency reduction was not different between CIH and controls at the ATP concentrations examined (1 mM: −13.7±7.6 vs −4.2± 8.7%; 10 mM: −36.7± 11.4 vs −31.3± 10.3%; 50 mM: −46.6± 2.7 vs −42.2±6.1%). Notwithstanding, an earlier recovery of the ATP-induced apneic responses was observed in CIH rats as compared to controls (Pb 0.05, Fig. 2B 2 ) . In contrast, the sympatho-excitatory responses evoked by 1 mM (71± 11 vs 41± 4%, Pb 0.05) or 10 mM (119± 17 vs 69±7%, P b 0.05), but not 50 mM of ATP (138± 12 vs 110± 20%), were significantly larger in CIH rats than in the controls (Fig. 3B) . The sites of ATP microinjections in the VLM were also histologically confirmed and are illustrated in Fig. 4. 
CIH selectively increased P2X3 and P2X4 receptor immunoreactivity in the VLM
Bands that correspond to glutamatergic receptors were observed at 110 kDa in VLM samples. The intensity of NMDAR1 (1.17 ± 0.07 vs 1.19 ± 0.15 a.u.) and GluR2/3 bands (1.32 ± 0.11 vs 1.57± 0.13 a.u., CIH and control groups respectively) did not differ between CIH (n= 4) and controls (n = 4, Fig. 3C ), suggesting that the density of these glutamatergic receptor subunities were not altered in the VLM after CIH. Moreover, well-defined bands at approximately 55 kDa identified the P2X1, P2X3, P2X4 and P2Y2 receptors in the VLM. The intensity of the P2X1 receptor immunoreactivity did not differ between CIH (n = 8) and control rats (n= 5 Fig. 3D . We conclude that CIH selectively increased the immunoreactivity for P2X3 and P2X4 receptors in the VLM, suggesting a functional relationship between CIH and the immunoreactive levels found for these particular purinoceptors in this brain area.
Discussion
In the present study, we verified that ATP and L-glutamate microinjections into the VLM of juvenile rats evoked excitatory effects on pre-sympathetic and expiratory neurons, eliciting increases of sympathetic activity combined with excitation of abdominal motor activity and inhibition of phrenic bursts. Concurrently, an increased P2X3 and P2X4 receptor immunoreactivity was observed in the VLM of CIH rats, which agrees with the functional observations that ATP microinjections in the VLM of CIH rats elicited larger sympathoexcitatory responses. In contrast, neither L-glutamate-evoked responses nor the immunoreactive density of glutamatergic receptors were modified by CIH, suggesting that CIH increased purinergic signaling in the VLM, affecting pre-sympathetic neurons controlling efferent sympathetic activity in juvenile rats.
L-glutamate is a major excitatory neurotransmitter acting on presympathetic neurons of VLM and on expiratory and inspiratory neurons of BötC and pre-BötC, respectively (Bianchi et al., 1995; Dampney et al., 2003) . Studies performed in anesthetized animals reported that L-glutamate microinjections in the VLM caused sympatho-excitation (Ross et al., 1984) associated with either phrenic inhibition at the level of BötC (Chitravanshi and Sapru, 1999; Monnier et al., 2003) (Monnier et al., 2003; Morgado-Valle and Feldman, 2007) . In the present study, we verified that L-glutamate microinjections into the VLM (caudal to facial nucleus) of unanesthetized in situ preparations elicited sympatho-excitatory and phrenic inhibitory responses associated with an increase in abdominal motor activity. These data are consistent with the notion that our L-glutamate microinjections were performed at the level of the BötC expiratory neurons. The excitation of these expiratory neurons was important not only to produce the inhibition of inspiratory neurons of VRC (Tian et al., 1999; Ezure et al., 2003; Smith et al., 2007) and cause phrenic inhibition, but also to excite the bulbo-spinal expiratory neurons of the caudal VRC, either by interneuron pathways (Molkov et al., 2010) or even directly (Ezure et al., 2003) , and increase the abdominal activity. With respect to the responses observed in the CIH group, the evoked sympathetic and respiratory alterations induced by L-glutamate microinjections into the VLM were similar to those observed in the control group. In addition, western blot analysis showed that the density of either NMDAR1 or GluR2/3 glutamatergic receptor subunities in the VLM
NMDA R1
GluR 2 Fig. 4 . Histological analysis confirming the microinjections sites of L-glutamate and ATP in the rostral ventrolateral medulla of control and CIH rats. Photomicrographs of brainstem coronal sections from a control (upper panels) and a CIH rat (bottom panels), combined with schematic drawings from Paxinos and Watson (1998) , showing the dye marker in the rostral VLM (left panels) and the approximate center of microinjections of all animals (right panels). Scale bar: 500 μm. NA: nucleus ambigus; BötC: Bötzinger complex; RVLM: rostral ventrolateral medulla; bas: basilar artery; py: pyramidal tract.
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were also similar in both groups. Therefore, these data indicate that ionotropic glutamatergic signaling may not be altered by CIH in the VLM of juvenile rats.
Accumulating experimental evidence points to a role for ATP, acting on P2X and P2Y receptors, in the control of sympathetic (Sun et al., 1992; Ralevic et al., 1999) and respiratory activities (Thomas et al., 2001; Huxtable et al., 2009 ). The present findings that microinjections of ATP into the rostral VLM of in situ preparations increased sympathetic activity and inhibited phrenic discharges agree with previous studies performed in anesthetized animals (Thomas et al., 2001 ) and show that ATP has an excitatory role on BötC neurons. The later, in turn, would produce the inhibition on inspiratory neurons and the excitation of bulbo-spinal expiratory caudal to VRC neurons, eliciting the responses of phrenic inhibition and abdominal excitation, as discussed in a previous paragraph. We have not ignored the possible contribution of adenosine, an active ATP metabolite, on the respiratory and sympathetic responses to microinjection of ATP into rostral VLM. Although we did not conduct experiments with adenosine receptor antagonists to preclude this possibility, we verified that rostral VLM microinjections of α,β,methyl-ATP, a non-hydrolysable purinergic receptor agonist, evoked similar patterns of respiratory and sympathetic responses as those elicited by ATP (data not shown). Moreover, adenosine applications in the VLM either increased or decreased arterial pressure (Thomas and Spyer, 1996) as well as depressed the respiratory neuronal activity (Vandam et al., 2008) , a finding that strongly suggests that the ATP-induced responses in the rostral VLM were mainly related to P2 receptor activation.
In CIH rats, we verified that the abdominal and phrenic responses evoked by ATP in the VLM were similar in magnitude to the control group. On the other hand, ATP-induced sympatho-excitatory responses were higher in the VLM of CIH rats than of controls. Consonant with increased functional responses, we observed a 20% increase in the P2X3 and P2X4 receptor immunoreactivity, evidencing a relationship between a higher sympatho-excitatory response and an augmented density of receptors. Altogether, these data strongly indicate that purinergic signaling is up-regulated in the rostral aspect of VLM. It would be exciting to examine the respiratory and sympathetic effects of P2X3 and P2X4 antagonists in the VLM of rats during CIH exposure; however, the lack of selective P2X receptor subtype antagonists (Burnstock, 2007) , will not allow interpreting correctly results derived from these protocols. In addition, there is scarce information available about the effective dose and blood brain barrier penetration of P2 receptors antagonists for in-vivo studies during CIH exposure, or the antagonist diffusion rates for acute brain microinjection protocols. Considering these strong limitations, we deemed not advisable to run antagonism experiments until more specific compounds become available and there is a clearer notion of the pharmacokinetics of these antagonists for in vivo studies.
P2 receptors are abundantly expressed in the brain and have a role on purinergic transmission acting both pre-and post-junctionally (Burnstock, 2007) . Immuno-histochemical and pharmacological studies demonstrate that P2X receptors play an excitatory role on presympathetic VLM neurons (Sun et al., 1992; Ralevic et al., 1999; Thomas et al., 2001) . The finding that the immunoreactive density of P2X3 and P2X4 receptors increased, while the P2X1 receptor was not modified by CIH is intriguing. Studies demonstrate that P2X3, or its P2X2/3 heteromeric form, are involved in the hypoxia-induced signaling in the carotid bodies (Prasad et al., 2001) . As far as at the central nervous system P2X3 receptors are mostly found in the brainstem (Burnstock, 2007) , this receptor subtype may be also important for VLM processing of chemoreflex-evoked responses, which might explain the selectivity of its alteration following CIH. In addition, Cavaliere et al. (2003) reported that in ischemia, the expression of P2X2 and P2X4 receptors is increased in the hippocampus, which indicates that hypoxia may modulate the expression of these receptors, and possibly their heteromeric forms.
Our findings are showing that the immunoreactivity of P2X3 and P2X4 receptors, but not other P2X or P2Y receptors, increased in the VLM of CIH rats, agreeing with the hypothesis that these receptors are important mediators of ATP-dependent responses evoked by hypoxia as well as this stimulus may modulate their expression. Several hypotheses might be raised to explain the increased immunoreactivity of P2X3 and P2X4 receptors. Among others, an increase rate of receptor synthesis, an increased stability of the mRNA coding for these receptors or a reduction in its degradation rate during CIH, might account for the increase in the receptor bands observed. Specific experiments need to be designed to distinguish between these alternatives. Notwithstanding, our data suggest that the enhanced P2X3 and P2X4 receptor density is functional since CIH increased the ATP responses of the pre-sympathetic VLM neurons, but not the respiratory neurons of BötC. The shorter apneic response to microinjections of ATP into the VLM in CIH rats might be associated with a possible faster rate of ATP metabolism at the VLM of rats submitted to CIH. Alternatively, it is also possible that inspiratory neurons in the vicinity of the sites of ATP microinjections, such as those from the pre-BötC (Sun et al., 1998; Lorier et al., 2007) , may be altered by CIH and activated by the ATP spread from the center of microinjection, contributing to the pattern of response observed in CIH. Additional experiments are needed to resolve these issues.
In summary, CIH enhanced sympatho-excitatory response to ATP microinjections into the VLM, possibly related to a specific increase in P2X3 and P2X4 receptor density in the VLM. In contrast, CIH does not affect glutamatergic signaling in the VLM of juvenile rats, revealing that CIH modified preferentially only some brain networks operating at the VLM. At present we cannot rule out the possibility that tonic glutamatergic transmission in VLM neurons of CIH rats is also modified, especially considering studies showing that the activation of pre-synaptic P2X3 and P2X2/3 agonists increase glutamatergic transmission on trigeminal neurons (Jennings et al., 2006) . Moreover, it has been recently described an important network involving Lglutamate, ATP, glial cells that modulate the neuronal activity in some brain regions, including the ventrolateral medulla (Huxtable et al., 2010) . The mechanisms that account for the increased purinergic signaling as well as the possible interaction between purinergic and glutamatergic mechanisms of the VLM in the respiratory and sympathetic alterations observed in CIH juvenile rats are matters for further investigations. The neurochemical and cell biology basis of how CIH triggers these unambiguous changes in the VLM neuronal network of juvenile rats warrants expanding our investigations. In this regard, it is of interest examining whether the expression of P2X3 and P2X4 receptors are controlled by transcriptional factors, including hypoxia induced factors (HIF-1 and HIF-2) which are known to be modulated in CIH (Nanduri et al., 2008; Prabhakar et al., 2009 ). Moreover, it will be important to analyze the role of the cell red-ox status and its regulation by HIF-1 and HIF-2, novel variables that are recently known to be critically involved in hypoxia (Prabhakar et al., 2009 ). Concomitantly, CIH may also directly or indirectly modify the release of ATP from purinergic pathways, influencing therefore the synaptic strength of VLM pathways. At the light of these novel observations, implying an increased purinergic transmission in CIH, related to increased functional sympatho-excitation responses, the understanding of the neurochemical mechanisms underlying hypertension in patients suffering from OSA might be clinically relevant.
